TGA Approval

POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion (330232)

ARTG ID

330232

ARTG Name

POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion

Sponsor

Kyowa Kirin Australia Pty Ltd

ARTG Date

February 5, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

KYOWA KIRIN AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/94bd0bcf11fc272162a0f679ba0c276c.pdf

https://medical-cdn.nocode.com/drug_tga/a7a2ce1b000b96bf265642857541ec98.pdf

Ingredient Name

mogamulizumab

Empowering clinical research with data-driven insights and AI-powered tools.

POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion (330232) - TGA 批准文号 | MedPath